Desloratadine ODT Rx
Generic Name and Formulations:
Desloratadine 2.5mg, 5mg; orally-disintegrating tabs; tutti-frutti flavor; contains phenylalanine.
Various generic manufacturers
Indications for Desloratadine ODT:
Seasonal allergic rhinitis (for patients ≥2yrs old). Perennial allergic rhinitis, chronic idiopathic urticaria (for patients ≥6 months old).
Adults and Children:
Dissolve on tongue; swallow with or without water. <6yrs: use other forms. 6–11yrs: 2.5mg once daily. ≥12yrs: 5mg once daily. Renal or hepatic impairment: initially 5mg every other day.
ODT: Phenylketonurics. Pregnancy (Cat.C). Nursing mothers: not recommended.
Pharyngitis, dry mouth or throat, myalgia, fatigue, somnolence, dysmenorrhea, headache, nausea, dizziness. Children: fever, diarrhea, upper respiratory infections, irritability, coughing.
Formerly known under the brand name Clarinex ODT.
Tabs (YES); syrup (NO)
Tabs—100, 500; Syrup—4oz, 16oz; ODT—contact supplier
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies